Ignite Creation Date:
2024-05-05 @ 10:14 PM
Last Modification Date:
2024-10-26 @ 10:16 AM
Study NCT ID:
NCT01066494
Status:
UNKNOWN
Last Update Posted:
2011-01-17
First Post:
2010-02-09
Brief Title:
A Pharmacokinetic and Efficacy Study of Amonafide L-malate AS1413 in Combination With Cytarabine in Patients With Acute Myeloid Leukemia AML
Sponsor:
Antisoma Research
Organization:
Antisoma Research
Study Overview
Official Title:
A Phase IIa Pharmacokinetic and Efficacy Study of Amonafide L-malate AS1413 in Combination With Cytarabine in Adult Patients With Acute Myeloid Leukemia AML
Status:
UNKNOWN
Status Verified Date:
2011-01
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A phase IIa study to evaluate the pharmacokinetic and efficacy of amonafide L-malate AS1413 in combination with cytarabine in treating patients with acute myeloid leukemia AML
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None